Urinary bladder cancer: Role of MR imaging

Radiographics

Volumn 32, Issue 2, 2012, Pages 371-387

  Verma, Sadhna ^a   Rajesh, Arumugam ^b   Prasad, Srinivasa R ^c   Gaitonde, Krishnanath ^a   Lall, Chandana G ^d   Mouraviev, Vladimir ^a   Aeron, Gunjan ^a   Bracken, Robert B ^a   Sandrasegaran, Kumaresan ^e  

^a UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

^b UNIVERSITY HOSPITALS OF LEICESTER NHS TRUST   (United Kingdom)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR;

AGED; ARTICLE; BLADDER TUMOR; CANCER INVASION; CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; CYSTOSCOPY; EARLY DIAGNOSIS; FEMALE; GENETICS; HUMAN; MALE; METHODOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; ONCOGENE RAS; PATHOLOGY; POSITRON EMISSION TOMOGRAPHY; RADIOGRAPHY; SENSITIVITY AND SPECIFICITY; SMOOTH MUSCLE; SQUAMOUS CELL CARCINOMA; TRANSITIONAL CELL CARCINOMA; UROGRAPHY;

AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CARCINOMA, TRANSITIONAL CELL; CYSTOSCOPY; EARLY DETECTION OF CANCER; FEMALE; FIBROBLAST GROWTH FACTORS; GENES, RAS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MUSCLE, SMOOTH; NEOPLASM INVASIVENESS; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED; URINARY BLADDER NEOPLASMS; UROGRAPHY;

EID: 84858129258     PISSN: 02715333     EISSN: 15271323     Source Type: Journal    
DOI: 10.1148/rg.322115125     Document Type: Article

References (44)

1. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin 2010;60(5):277-300.
2. Avritscher EB, Cooksley CD, Grossman HB, et al. Clinical model of lifetime cost of treating bladder cancer and associated complications. Urology 2006; 68(3):549-553.
3. Yabroff KR, Lamont EB, Mariotto A, et al. Cost of care for elderly cancer patients in the United States. J Natl Cancer Inst 2008;100(9):630-641.
4. Skinner DG, Lieskovsky G, eds. Diagnosis and management of genitourinary cancer. Philadelphia, Pa: Saunders, 1988.
5. Murphy WM, Grignon DJ, Perlman EJ. Tumors of the kidney, bladder, and related urinary structures. AFIP Atlas of Tumor Pathology, ser 4. Washington, DC: American Registry of Pathology, 2004.
6. Kirkali Z, Chan T, Manoharan M, et al. Bladder cancer: epidemiology, staging and grading, and diagnosis. Urology 2005;66(6 suppl 1):4-34.
7. Murta-Nascimento C, Schmitz-Dräger BJ, Zeegers MP, et al. Epidemiology of urinary bladder cancer: from tumor development to patient's death. World J Urol 2007;25(3):285-295.
8. Zeegers MP, Tan FE, Dorant E, van Den Brandt PA. The impact of characteristics of cigarette smoking on urinary tract cancer risk: a meta-analysis of epidemiologic studies. Cancer 2000;89(3):630-639.
9. Steiner H, Bergmeister M, Verdorfer I, et al. Early results of bladder-cancer screening in a high-risk population of heavy smokers. BJU Int 2008;102(3): 291-296.
10. Aben KK, Witjes JA, Schoenberg MP, Hulsbergen-van de Kaa C, Verbeek AL, Kiemeney LA. Familial aggregation of urothelial cell carcinoma. Int J Cancer 2002;98(2):274-278.
11. Czene K, Lichtenstein P, Hemminki K. Environmental and heritable causes of cancer among 9.6 million individuals in the Swedish Family-Cancer Database. Int J Cancer 2002;99(2):260-266.
12. Saad A, Hanbury DC, McNicholas TA, Boustead GB, Morgan S, Woodman AC. A study comparing various noninvasive methods of detecting bladder cancer in urine. BJU Int 2002;89(4):369-373.
13. Sadow CA, Silverman SG, O'Leary MP, Signorovitch JE. Bladder cancer detection with CT urography in an academic medical center. Radiology 2008; 249(1):195-202.
14. Pashos CL, Botteman MF, Laskin BL, Redaelli A. Bladder cancer: epidemiology, diagnosis, and management. Cancer Pract 2002;10(6):311-322.
15. Cote RJ, Dunn MD, Chatterjee SJ, et al. Elevated and absent pRb expression is associated with bladder cancer progression and has cooperative effects with p53. Cancer Res 1998;58(6):1090-1094.
16. Wu XR. Urothelial tumorigenesis: a tale of divergent pathways. Nat Rev Cancer 2005;5(9):713-725.
17. Shariat SF, Karakiewicz PI, Ashfaq R, et al. Multiple biomarkers improve prediction of bladder cancer recurrence and mortality in patients undergoing cystectomy. Cancer 2008;112(2):315-325.
18. Sexton WJ, Wiegand LR, Correa JJ, Politis C, Dickinson SI, Kang LC. Bladder cancer: a review of non-muscle invasive disease. Cancer Contr 2010;17(4): 256-268.
19. Wong-You-Cheong JJ, Woodward PJ, Manning MA, Sesterhenn IA. Neoplasms of the urinary bladder: radiologic-pathologic correlation. RadioGraphics 2006;26(2):553-580.
20. Greene FL, Page DL, Fleming ID, et al, eds. Urinary bladder. In: AJCC cancer staging manual. 6th ed. New York, NY: Springer-Verlag, 2002; 335-340.
21. Dutta SC, Smith JA Jr, Shappell SB, Coffey CS, Chang SS, Cookson MS. Clinical under staging of high risk nonmuscle invasive urothelial carcinoma treated with radical cystectomy. J Urol 2001;166(2): 490-493.
22. Ficarra V, Dalpiaz O, Alrabi N, Novara G, Galfano A, Artibani W. Correlation between clinical and pathological staging in a series of radical cystectomies for bladder carcinoma. BJU Int 2005;95(6): 786-790.
23. Herr HW. The value of a second transurethral resection in evaluating patients with bladder tumors. J Urol 1999;162(1):74-76.
24. Bradford TJ, Montie JE, Hafez KS. The role of imaging in the surveillance of urologic malignancies. Urol Clin North Am 2006;33(3):377-396.
25. Beyersdorff D, Zhang J, Schöder H, Bochner B, Hricak H. Bladder cancer: can imaging change patient management? Curr Opin Urol 2008;18(1): 98-104.
26. Caterino M, Giunta S, Finocchi V, et al. Primary cancer of the urinary bladder: CT evaluation of the T parameter with different techniques. Abdom Imaging 2001;26(4):433-438.
27. Caoili EM, Cohan RH, Inampudi P, et al. MDCT urography of upper tract urothelial neoplasms. AJR Am J Roentgenol 2005;184(6):1873-1881.
28. Cowan NC, Turney BW, Taylor NJ, McCarthy CL, Crew JP. Multidetector computed tomography urography for diagnosing upper urinary tract urothelial tumour. BJU Int 2007;99(6):1363-1370.
29. Turney BW, Willatt JM, Nixon D, Crew JP, Cowan NC. Computed tomography urography for diagnosing bladder cancer. BJU Int 2006;98(2):345-348.
30. Knox MK, Cowan NC, Rivers-Bowerman MD, Turney BW. Evaluation of multidetector computed tomography urography and ultrasonography for diagnosing bladder cancer. Clin Radiol 2008;63(12): 1317-1325.
31. Tsampoulas C, Tsili AC, Giannakis D, Alamanos Y, Sofikitis N, Efremidis SC. 16-MDCT cystoscopy in the evaluation of neoplasms of the urinary bladder. AJR Am J Roentgenol 2008;190(3):729-735.
32. Semelka RC. Abdominal-pelvic MRI. Hoboken, NJ: Wiley-Blackwell, 2010.
33. Lawler LP. MR imaging of the bladder. Radiol Clin North Am 2003;41(1):161-177.
34. Barentsz JO, Ruijs SH, Strijk SP. The role of MR imaging in carcinoma of the urinary bladder. AJR Am J Roentgenol 1993;160(5):937-947.
35. Hood MN, Ho VB, Smirniotopoulos JG, Szumowski J. Chemical shift: the artifact and clinical tool revisited. RadioGraphics 1999;19(2):357-371.
36. Tekes A, Kamel I, Imam K, et al. Dynamic MRI of bladder cancer: evaluation of staging accuracy. AJR Am J Roentgenol 2005;184(1):121-127.
37. Kim B, Semelka RC, Ascher SM, Chalpin DB, Carroll PR, Hricak H. Bladder tumor staging: comparison of contrast-enhanced CT, T1- and T2-weighted MR imaging, dynamic gadolinium-enhanced imaging, and late gadolinium-enhanced imaging. Radiology 1994;193(1):239-245.
38. Neuerburg JM, Bohndorf K, Sohn M, Teufl F, Guenther RW, Daus HJ. Urinary bladder neoplasms: evaluation with contrast-enhanced MR imaging. Radiology 1989;172(3):739-743.
39. Neuerburg JM, Bohndorf K, Sohn M, Teufl F, Günther RW. Staging of urinary bladder neoplasms with MR imaging: is Gd-DTPA helpful? J Comput Assist Tomogr 1991;15(5):780-786.
40. Hayashi N, Tochigi H, Shiraishi T, Takeda K, Kawamura J. A new staging criterion for bladder carcinoma using gadolinium-enhanced magnetic resonance imaging with an endorectal surface coil: a comparison with ultrasonography. BJU Int 2000;85 (1):32-36.
41. Verma S, Rajesh A, Morales H, et al. Assessment of aggressiveness of prostate cancer: correlation of apparent diffusion coefficient with histologic grade after radical prostatectomy. AJR Am J Roentgenol 2011;196(2):374-381.
42. Hatano K, Tsuda K, Kawamura N, et al. Clinical value of diffusion-weighted magnetic resonance imaging for localization of prostate cancer: comparison with the step sections of radical prostatectomy [in Japanese]. Nippon Hinyokika Gakkai Zasshi 2010; 101(4):603-608.
43. Kitajima K, Kaji Y, Fukabori Y, Yoshida K, Suganuma N, Sugimura K. Prostate cancer detection with 3 T MRI: comparison of diffusion-weighted imaging and dynamic contrast-enhanced MRI in combination with T2-weighted imaging. J Magn Reson Imaging 2010;31(3):625-631.
44. 2. AJR Am J Roentgenol 2010;194(1):W33- W37.